GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (NSE:ASTRAZEN) » Definitions » Gross-Profit-to-Asset %

AstraZeneca Pharma India (NSE:ASTRAZEN) Gross-Profit-to-Asset % : 62.28% (As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. AstraZeneca Pharma India's annualized Gross Profit for the quarter that ended in Dec. 2024 was ₹7,730 Mil. AstraZeneca Pharma India's average Total Assets over the quarter that ended in Dec. 2024 was ₹12,413 Mil. Therefore, AstraZeneca Pharma India's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 62.28%.


AstraZeneca Pharma India Gross-Profit-to-Asset % Historical Data

The historical data trend for AstraZeneca Pharma India's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Pharma India Gross-Profit-to-Asset % Chart

AstraZeneca Pharma India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.44 64.55 54.94 62.75 60.33

AstraZeneca Pharma India Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.19 33.75 58.28 58.67 62.28

Competitive Comparison of AstraZeneca Pharma India's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, AstraZeneca Pharma India's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca Pharma India's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca Pharma India's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where AstraZeneca Pharma India's Gross-Profit-to-Asset % falls into.


;
;

AstraZeneca Pharma India Gross-Profit-to-Asset % Calculation

AstraZeneca Pharma India's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=6222.7/( (9848.7+10780.3)/ 2 )
=6222.7/10314.5
=60.33 %

AstraZeneca Pharma India's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=7730.4/( (12413+0)/ 1 )
=7730.4/12413
=62.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


AstraZeneca Pharma India Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca Pharma India Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045
AstraZeneca Pharma India Ltd is engaged in the manufacture, trading, and marketing of pharmaceutical products. Its only operating segment is Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of its revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation, Autoimmunity, Neuroscience Infection and Vaccines.

AstraZeneca Pharma India Headlines

No Headlines